Hepatitis b vaccines - PowerPoint PPT Presentation


Autumn/winter Campaigns

HSE advertising campaigns promoting autumn/winter vaccines and healthcare options for the 2023-2024 season. Themes include top-up vaccines, children's flu shots, pregnancy vaccines, and care advice. Get informed and stay healthy!

1 views • 15 slides


Veterinary Vaccines Market Poised for Growth, Predicts Meticulous Research®

Veterinary vaccines are integral to the veterinary healthcare industry as they help prevent diseases and their spread. They also reduce the risk of transmission of infections from household pets to their owners. Several types of vaccines, such as live attenuated, inactive, recombinant, and other vac

0 views • 3 slides



Protecting Pregnant Women and Babies: Winter Vaccination Campaign 2023

As part of the HSE's Autumn-Winter Vaccinations campaign, the NIO has designed a partner pack promoting flu, COVID-19, and whooping cough vaccines for pregnant women. The campaign emphasizes the importance of getting vaccinated during pregnancy to safeguard both the mother and baby from serious illn

1 views • 10 slides


Guidelines for Treating Chronic Hepatitis C Virus Infection

Clinical guidelines provide evidence-based recommendations for treating and curing chronic HCV infection in adults to improve treatment rates, reduce morbidity and mortality, and support the New York State Hepatitis C Elimination Plan. Recommendations include considerations in HCV treatment initiati

0 views • 28 slides


Epidemiology of hepatitis C in Ireland

Hepatitis C, a viral infection affecting the liver, has notable implications in Ireland, with key transmission routes, clinical manifestations, and long-term consequences shaping its epidemiology. From transmission patterns to chronic infection risks, understanding the natural history and prevalence

0 views • 24 slides


Understanding Vaccines and Immunization

Explore the world of vaccines and immunization, learning about active and passive immunity, childhood and adult immunization schedules, common vaccines, contraindications, adverse effects, and the importance of immunization in preventing diseases. Discover the process of immunization and how it stim

2 views • 27 slides


Insights on Experimental ASF Vaccines in Pig Studies

The research conducted by Prof. Jishu Shi and his team at Kansas State University delves into the safety and efficacy testing of experimental African Swine Fever (ASF) vaccines using pigs as the model. Various vaccines, including DNA vaccines and live attenuated viruses, were tested against differen

4 views • 13 slides


Exploring Edible Vaccines: Advantages, Limitations, and Significance

Edible vaccines, a novel approach in vaccine technology, offer numerous advantages such as easy administration, cost-effectiveness, and enhanced immunity. However, they also present challenges like dosage consistency, stability issues, and potential side effects. The significance of edible vaccines

0 views • 9 slides


Meticulous Research® Predicts Vaccines Market to Reach $71.50 Billion by 2031

Vaccines Market Size, Share, Forecast, & Trends Analysis by Indication (Pneumococcal, Influenza, HPV, DTP, MMR, Hepatitis, COVID-19) Administration (IM, SC, Oral) Type (Inactivated, Combination) Valence (Multivalent, Monovalent) - Global Forecast to 2031\n

1 views • 5 slides


Veterinary Vaccination Guidelines and Regulation Overview

This presentation provides an overview of veterinary vaccination guidelines and regulations, covering topics such as the National Veterinary Stockpile, types of vaccines, vaccine delivery, storage, and handling. It also discusses the regulatory framework governing veterinary vaccines and the role of

5 views • 30 slides


Vaccines Market - A Comprehensive Analysis – 2024

Vaccines Market Size, Share, Forecast, & Trends Analysis by Indication (Pneumococcal, Influenza, HPV, DTP, MMR, Hepatitis, COVID-19) Administration (IM, SC, Oral) Type (Inactivated, Combination) Valence (Multivalent, Monovalent) - Global Forecast to

0 views • 4 slides


Ethiopia's Initial Experience on Hepatitis B Birth Dose Pilot Implementation

Ethiopia's initial experience on Hepatitis B birth dose (HepB-BD) pilot implementation includes background statistics, HBsAg prevalence, hepatitis B vaccination coverage, distribution of HBV infection, existing guidelines/strategies, and activities prior to the start of HepB-BD piloting.

0 views • 17 slides


COVID-19 Vaccines Regulatory Status Update - SAHPRA Review Details

Update on COVID-19 vaccine regulatory status as of January 25, 2021, provided by Dr. B. Semete-Makokotlela, SAHPRA CEO. The update includes information on vaccine applications submitted to SAHPRA, regulatory reviews conducted, and Section 21 applications for vaccines like Janssen, AstraZeneca, and C

1 views • 13 slides


Clinical Excellence in Hepatitis C Nursing: SCENS Program Overview

Demonstrating competency in infection control, abdominal assessment, specimen collection, and communication is crucial in nursing care for patients with Hepatitis C. The SCENS program focuses on key learning objectives to enhance clinical proficiency, address potential issues, and understand the com

0 views • 12 slides


Hepatitis B Vaccines: Genuine vs Counterfeit - Insights from Uganda National Drug Authority

Explore the difference between genuine and counterfeit Hepatitis B vaccines in Uganda, as detailed by the National Drug Authority. Learn about the authorized vaccine on the market, counterfeit batch numbers, fake addresses on invoices/receipts, and the availability of vaccines in private sectors. St

0 views • 8 slides


Understanding OSHA Bloodborne Pathogens Training and Hepatitis B Virus

Covering the basics of OSHA Bloodborne Pathogens Standard, this training material provides essential information on bloodborne pathogens, including Hepatitis B Virus (HBV). It emphasizes the importance of training for individuals with occupational exposure, outlining crucial topics such as Hepatitis

2 views • 56 slides


Canine Infectious Hepatitis (ICH) - Overview, Symptoms, and Treatment

Canine Infectious Hepatitis (ICH), also known as Rubarth's Disease, is caused by Canine Adenovirus-1 (CAdV-1), affecting dogs of all ages. The virus primarily targets hepatocytes, leading to acute hepatitis, as well as respiratory and ocular issues. Transmission occurs through contact with infected

6 views • 7 slides


Hepatitis B BD Introduction Plan in Ghana

In Ghana, the introduction plan for Hepatitis B BD involves evaluating disease burden, estimating seroprevalence among pregnant women, obtaining necessary approvals, presenting evidence to NITAG, and seeking support for introduction. A policy for screening and prevention is in place, aiming to addre

1 views • 10 slides


Introduction of Hepatitis B Birth Dose in Mozambique: A Step Towards Comprehensive Prevention

Mozambique is gearing up to introduce the Hepatitis B birth dose as a strategic approach in its immunization program, aiming to tackle the high prevalence of HBV within the population, particularly among women and HIV-positive individuals. The country's existing policies on screening pregnant women

0 views • 15 slides


Understanding Immunization: Types and Vaccines Explained

Immunization against infectious diseases has been a major success in medicine, with active immunization using vaccines providing protection. This article discusses the different types of vaccines including live attenuated, killed or inactivated, toxoids, and cellular fractions, highlighting their ch

1 views • 13 slides


National Viral Hepatitis Control Program - Achieving Universal Health Coverage and Elimination Goals

The National Viral Hepatitis Control Program in India is working towards combating viral hepatitis and achieving SDG goal 3.3 through a comprehensive approach that includes awareness generation, prevention, management, and financing under the NHM. The aim is to eliminate hepatitis C by 2030, reduce

0 views • 19 slides


COVID-19 Vaccines: Safety, Effectiveness, Development, and Trust

COVID-19 vaccines authorized in the US have undergone rigorous safety assessments with large trial participant numbers. The FDA and CDC actively monitor for any safety signals. The vaccines are proven safe and effective, developed quickly due to global collaboration and resources. Trust in the vacci

0 views • 12 slides


Debunking Myths About COVID-19 Vaccines During Pregnancy

Addressing myths and misinformation about COVID-19 vaccines and pregnancy, this content provides accurate information on the safety and benefits of getting vaccinated during pregnancy. Expert insights from healthcare professionals emphasize the importance of vaccination for pregnant individuals and

0 views • 22 slides


Understanding Vaccine Safety, Effectiveness, and Side Effects: A Guide to Better Living

This informative content delves into vaccine safety, effectiveness, and side effects, offering insights into the development stages of vaccines, COVID-19 vaccine comparisons, and an overview of COVID-19 vaccine development. It also explains how vaccines work to protect against viruses and emphasizes

0 views • 33 slides


Overview of Measles-Containing Vaccines Supply and Demand through UNICEF

The supply and demand dynamics of measles-containing vaccines (MCV) procured through UNICEF are explored, highlighting the total value of vaccines procured, the impact on humanitarian situations, and the challenges faced in forecasting and production. UNICEF works with multiple manufacturers for MCV

0 views • 7 slides


Elimination of Hepatitis C in Individuals With HIV Infection

Discussing the goals, treatment options, and global impact of Hepatitis C in individuals with HIV infection, this presentation by Dr. David L. Thomas from Johns Hopkins Medical Institutions sheds light on important aspects such as mortality projections, WHO elimination goals, and targets for hepatit

0 views • 40 slides


Decline of Hepatitis C in England: 2022 Report Highlights

The 2022 report on Hepatitis C in England shows a continued decline in the prevalence of chronic HCV infection, with around 81,000 individuals estimated to be affected in 2020. The report also highlights the distribution of infections among individuals with different drug injecting histories. Data f

0 views • 41 slides


Understanding COVID-19 Vaccination: Myths, Facts, and Global Impact

Learn about the Phase One Inoculation Webinar, dispel vaccine myths and misinformation, understand the relationship between 5G and viruses, compare COVID-19 cases and deaths globally, and discover the importance of vaccination in saving lives. The content emphasizes the distinction between myths and

0 views • 8 slides


Understanding COVID-19 Vaccines: Safety, Effectiveness, and Immunity

COVID-19 vaccines play a crucial role in preventing illness by helping the body develop immunity to the SARS-CoV-2 virus. Vaccines like Pfizer-BioNTech and Moderna utilize mRNA technology to trigger the immune system to produce antibodies against the virus. These vaccines are safe, effective, and pr

0 views • 15 slides


Hepatitis C Screening Recommendations for Adults (2017)

The Canadian Task Force on Preventive Health Care (CTFPHC) released recommendations on Hepatitis C screening for adults in 2017. The guidelines provide an overview of screening methods, key findings, implementation considerations, and conclusions. Those at higher risk for HCV in Canada include indiv

0 views • 38 slides


Understanding Zoonotic Hepatitis A Virus Infections

Zoonotic hepatitis A virus infections primarily affect humans and nonhuman primates, with transmission occurring through fecal-oral route. This article delves into the reservoir, mode of transmission, clinical signs, and diagnosis of hepatitis A, shedding light on its impact on both species. Nonhuma

0 views • 22 slides


Epidemiology of Hepatitis B and C in Florida: 2019 Data Analysis

The Department of Health in Florida has released the 2019 data on the epidemiology of Hepatitis B and C as of January 21, 2021. The report includes information on acute and chronic cases, technical notes on case definitions, and changes in national case definitions in 2020. Acute cases require speci

0 views • 35 slides


Understanding Viral Hepatitis: Causes, Types, and Clinical Symptoms

Viral hepatitis is caused by various hepatotropic viruses, including Hepatitis A, B, C, D, and E. This type of liver inflammation can manifest acutely or chronically, leading to symptoms such as jaundice, abdominal pain, nausea, and fatigue. Hepatitis A virus, in particular, is primarily transmitted

0 views • 36 slides


Overview of Hepatitis B Infection in Ireland: Epidemiology, Transmission, and Prevention

Hepatitis B infection is a viral liver disease transmitted through various means such as contact with infected body fluids. The virus can lead to acute or chronic infection, potentially causing severe liver complications. Vaccination programs and lifelong treatment options aim to manage and prevent

0 views • 30 slides


Understanding COVID-19 Vaccines and Prevention Measures

This presentation covers essential information on COVID-19, its symptoms, ways to reduce the risk of infection, and the importance of vaccines. It explains how vaccines work, focusing on mRNA vaccines and their role in developing immunity. The content emphasizes the significance of public health mea

0 views • 23 slides


Developing Country-Specific Vaccines for Foot and Mouth Disease Control in Pakistan

In Pakistan, Foot and Mouth Disease (FMD) vaccination plays a crucial role in protecting animals, but challenges with locally manufactured and imported vaccines have hindered effectiveness. To address this, the development of country-specific FMD vaccines tailored to circulating virus strains has be

0 views • 14 slides


Liver Disease in Canada: An Assessment of the Current Situation

Liver disease in Canada, particularly hepatitis B, is a concerning issue highlighted in the report prepared by the Canadian Liver Foundation in March 2013. The incidence of acute hepatitis B is declining, especially among vaccinated age groups. The prevalence of chronic hepatitis B in Canadian immig

0 views • 58 slides


Hepatitis E Surveillance and Notifications in Ireland

The surveillance and notification of Hepatitis E cases in Ireland have been detailed, including the introduction of universal blood donor screening, notifiable disease status, and enhanced surveillance measures. The data shows trends in notifications, blood donor screening results, clinical cases, a

0 views • 13 slides


Impact of COVID-19 Response on Hepatitis Elimination in the Americas

The data presented focuses on the impact of the COVID-19 response on hepatitis elimination efforts in the Americas region. It includes information on changes in in-person clinic visits, declines in hepatitis B and C screening and treatment, and disruptions in opioid substitution therapy. The graphs

0 views • 13 slides


Advancing Global Health Through Innovation in Vaccines and Medicines

This initiative supports the development of affordable vaccines and medicines for diseases affecting developing countries. It aligns with the Doha Declaration on Public Health, emphasizing access to essential healthcare. A virtual reality robotic surgical practice is proposed to enhance medical care

0 views • 14 slides